Suramin blocks the binding of interleukin-1 to its receptor and neutralizes IL-1 biological activities
- 30 November 1994
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 16 (11) , 931-939
- https://doi.org/10.1016/0192-0561(94)00054-9
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo.Journal of Clinical Investigation, 1993
- Role of Interleukin‐l in Infectious DiseasesImmunological Reviews, 1992
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Suramin Blockade of Insulinlike Growth Factor I-Stimulated Proliferation of Human Osteosarcoma CellsJNCI Journal of the National Cancer Institute, 1990
- cDNA Expression Cloning of the IL-1 Receptor, a Member of the Immunoglobulin SuperfamilyScience, 1988
- Inhibition of Human Immunodeficiency Virus Type I Reverse Transcriptase by Suramin-related CompoundsJournal of General Virology, 1987
- Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cellsJournal of Cellular Physiology, 1987
- Analysis of radioligand binding experimentsJournal of Pharmacological Methods, 1985
- Detection and characterization of high affinity plasma membrane receptors for human interleukin 1.The Journal of Experimental Medicine, 1985
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980